Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 166 Harbin 6 Zhengzhou 5 Chongqing 5 Wuhan 5
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital271 Beijing Tiantan Hospital219 Cancer Institute and Hospital, Chinese Academy of Medical Sciences205 AstraZeneca191 Peking University People's Hospital166 Clear sponsor filter
Site location
Beijing166 Harbin6 Zhengzhou5 Chongqing5 Wuhan5
All 33 locations
Target enrolment
to

Trials with a site in Beijing

166 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
ADC Based Therapy Accroding to HER2 Heterogeneous
NCT07844018Breast Cancer (Early Breast Cancer)
Peking University People's Hospital
Phase 2
88
Beijing
2027-01-01
Not yet open
Peking University People's Hospital
Not applicable
160
Beijing
2027-01-01
Not yet open
Peking University People's Hospital
Not applicable
50
Beijing
2026-11-01
Not yet open
Peking University People's Hospital
Phase 2
100
Beijing
2026-11-01
Not yet open
Busulfan-Based Versus TBI-Based Conditioning for Adult ALL-CR2 Allo-HSCT
NCT07919470Acute Lymphoblastic Leukemia, Hematopoietic Stem Cell Transplantation
Peking University People's Hospital
Not applicable
180
Beijing
2026-11-01
Recruiting
Hemophagocytic Lymphohistiocytosis After Allogeneic Stem Cell Transplantation
NCT07905066Hemophagocytic Lymphohistiocytosis (HLH)
Peking University People's Hospital
Observational
10,000
Beijing
2026-10-19
Recruiting
Prospective ctDNA Testing in Large B-Cell Lymphoma
NCT07878351Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma
Peking University People's Hospital
Observational
100
Beijing
2026-10-15
Not yet open
The Effect of Different Delivery Positions on Pelvic Floor Function.
NCT07081321Stress Urinary Incontinence (SUI)
Peking University People's Hospital
Not applicable
1,992
Beijing
2026-09-20
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
NCT07796516Difficult-to-treat Rheumatoid Arthritis, Rheumatoid Arthritis
DrugTelitacicept
Peking University People's Hospital
Phase 2
420
Hefei, Beijing, Chongqing, Quanzhou, Guangzhou, Jiangmen, Shenzhen, Nanning
2026-09-01
Not yet open
Effect of Inspired Oxygen Concentration on Postoperative Atelectasis After VATS Lobectomy
NCT07721558Atelectasis, Postoperative Pulmonary Complications
Peking University People's Hospital
Not applicable
100
Beijing
2026-09-01
Recruiting
Peking University People's Hospital
Not applicable
50
Beijing
2026-09-01
Not yet open
Corticotropin for Behçet's Disease: A Multicenter Randomized Controlled TrialAcronym.
NCT07833163Behçet's Syndrome, Behçet's Syndrome (BS)
DrugACTH
Peking University People's Hospital
Phase 2
60
Beijing
2026-09
Not yet open
Efficacy and Safety of Low-Dose IL-2 in Neuromyelitis Optica Spectrum Disorder
NCT07809724Neuromyelitis Optica Spectrum Disorder (NMOSD)
DrugAldesleukin
Peking University People's Hospital
Phase 2
60
Beijing
2026-08-30
Not yet open
Real-World Efficacy and Safety of Tenapanor Plus Phosphate Binders in Hemodialysis Patients With Hyperphosphatemia
NCT07776119CKD 5D, Hemodialysis, Hyperphosphatemia Undergoing Hemodialysis
Peking University People's Hospital
Observational
200
Beijing
2026-08-20
Recruiting
MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer
NCT07894458Lung Neoplasms, Neoadjuvant Therapy, Immunotherapy, Minimal Residual Disease
Peking University People's Hospital
Not applicable
100
Beijing
2026-08-12
Recruiting
Peking University People's Hospital
Observational
40
Beijing
2026-08-04
Recruiting
Comprehensive Assessment System for Fallopian Tube Function and Clinical Study on Individualized Treatment Strategies
NCT07808229Multidimensional Tubal Function Assessment and Individualized Treatment Strategies for Tubal Factor Infertility
Peking University People's Hospital
Not applicable
240
Beijing
2026-08-01
Recruiting
Peking University People's Hospital
Phase 2
120
Beijing
2026-07-15
Not yet open
Peking University People's Hospital
Phase 2
32
Beijing
2026-07-15
Recruiting
Peking University People's Hospital
Phase 4
500
Beijing
2026-07-06
Recruiting
Peking University People's Hospital
Observational
140
Beijing
2026-07-01
Not yet open
Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia
NCT07714070Endometrial Neoplasms, Endometrial Cancer, Atypical Endometrial Hyperplasia, Progestin Resistance
DrugsOrlistat·Progestin
Peking University People's Hospital
Phase 2
48
Beijing
2026-07
Recruiting
Peking University People's Hospital
Not applicable
180
Beijing
2026-06-15
Not yet open
Peking University People's Hospital
Observational
4,750
Beijing
2026-06-01
Not yet open
Peking University People's Hospital
Not applicable
50
Beijing
2026-06-01
Not yet open
Peking University People's Hospital
Observational
55
Beijing
2026-06-01
Recruiting
A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA
NCT07586735Severe Aplastic Anemia, Aplastic Anaemia, Hematopoietic Cell Transplant
Peking University People's Hospital
Observational
64
Beijing
2026-06
Not yet open
Peking University People's Hospital
Phase 3
192
Beijing
2026-05-30
Recruiting
Peking University People's Hospital
Early Phase 1
18
Beijing
2026-05-29
Recruiting
IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)
NCT07617740REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
DrugIASO207
Peking University People's Hospital
Early Phase 1
18
Beijing
2026-05-25
Recruiting
Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML
NCT07617285AML, Refractory/Relapse Acute Myeloid Leukemia
Peking University People's Hospital
Phase 1
27
Beijing
2026-05-07
Not yet open
Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain
NCT07593365Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Breast Cancer, Pain Alleviation
Peking University People's Hospital
Not applicable
216
Beijing
2026-05-06
Recruiting
Peking University People's Hospital
Observational
60
Beijing
2026-05-01
Recruiting
CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment
NCT07366112Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer
Peking University People's Hospital
Phase 2
158
Beijing
2026-04-20
By invitation
Peking University People's Hospital
Phase 2
40
Beijing
2026-04-01
Not yet open
Peking University People's Hospital
Not applicable
60
Beijing
2026-04-01
Not yet open
Peking University People's Hospital
Not applicable
15
Beijing
2026-04
Recruiting
Peking University People's Hospital
Observational
100
Beijing
2026-03-20
Recruiting
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
NCT07487883Non-Small Cell Lung Cancer, Malignant Neoplasm, Pulmonary Nodules, PET/CT
Peking University People's Hospital
Observational
80
Beijing
2026-03-18
Recruiting
Baricitinib for Post-HSCT Persistent Thrombocytopenia
NCT07535645Persistent Thrombocytopenia, Allogeneic Hematopoietic Stem Cell Transplantation
DrugBaricitinib
Peking University People's Hospital
Phase 1/2
28
Beijing
2026-03-09
Recruiting
Peking University People's Hospital
Phase 1/2
56
Beijing
2026-03-05
Recruiting
Peking University People's Hospital
Not applicable
30
Beijing
2026-03-04
Recruiting
Peking University People's Hospital
Not applicable
200
Beijing
2026-03-03
Not yet open
IFN-α in Relapse Prevention.
NCT07449286Acute Myeloid Leukemia, Myelodysplastic Syndromes
DrugIFN-α
Peking University People's Hospital
Phase 2
100
Beijing
2026-03-01
Recruiting
Peking University People's Hospital
Not applicable
31
Beijing
2026-02-13
Recruiting
Peking University People's Hospital
Phase 2
39
Beijing, Xi'an
2026-02-10
Active, closed
Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning
NCT07509632Rectal Cancers, Pathological Complete Response, Neoadjuvant Chemoradiotherapy, Machine Learning
Peking University People's Hospital
Observational
320
Beijing
2026-02-04
Recruiting
Peking University People's Hospital
Not applicable
40
Beijing
2026-01-10
Active, closed
Peking University People's Hospital
Phase 2
42
Beijing
2026-01-10
Recruiting
Peking University People's Hospital
Early Phase 1
18
Beijing
2026-01-07
Not yet open
Critical Illness After Hematopoietic Cell Transplantation
NCT07328724Critical Illness, Ventilated Patients, Hematopoetic Stem Cell Transplantation, Transplant Complication
Peking University People's Hospital
Observational
4,000
Beijing, Chongqing, Hangzhou, Harbin, Tianjin, Wuhan
2026-01-01
Recruiting
Peking University People's Hospital
Early Phase 1
132
Beijing
2026-01-01
Recruiting
Peking University People's Hospital
Observational
4,800
Beijing
2026-01-01
Recruiting
Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT
NCT06946654Elderly, Geriatric Assessment, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Peking University People's Hospital
Observational
176
Beijing
2026-01-01
Recruiting
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
NCT07349498Hematopoietic Stem Cell Transplantation, Transplant Complication, Cardiovascular Events
Peking University People's Hospital
Observational
10,000
Beijing, Chongqing, Guangzhou, Shenzhen, Harbin, Zhengzhou, Wuhan, Xi'an
2026-01-01
Recruiting
Peking University People's Hospital
Not applicable
307
Beijing
2026-01-01
Recruiting
Ablation Compare With Surgery for Early Breast Cancer
NCT07484087Breast Cancer, Early Stage, Hormone Receptor Positive, Ablation
Peking University People's Hospital
Not applicable
264
Beijing
2026-01-01
Not yet open
Peking University People's Hospital
Observational
159
Beijing
2025-12-30
Recruiting
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors
NCT07586813Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gastrointestinal Neoplasms, Pancreatic Cancer
DrugsTretinoin·All-trans retinoic acid·ATRA·Ipilimumab
Peking University People's Hospital
Phase 2
220
Beijing
2025-12-22
Recruiting
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
NCT07586826Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gynecologic Cancers, Ovarian Cancer
DrugsTretinoin·All-trans retinoic acid·ATRA·Ipilimumab
Peking University People's Hospital
Phase 2
220
Beijing
2025-12-22
Active, closed
the Exploration of MTAP Deletion in Osteosarcoma by Immunohistochemistry
NCT07593573Osteosarcoma, MTAP Deletion, Immunohistochemistry
Peking University People's Hospital
Observational
100
Beijing
2025-12-15
Recruiting
CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
NCT07441291B ALL, Allogenetic Hematopoietic Stem Cell Transplantation, MRD-positive
DrugCar-T
Peking University People's Hospital
Phase 3
70
Beijing
2025-11-30
Recruiting
A Prediction Model in Pregnant Women With Aplastic Anemia
NCT07101770Aplastic Anemia, Pregnancy, Prediction Model
Peking University People's Hospital
Observational
300
Beijing
2025-11-27
Recruiting
Real-world Study of Aflibercept 8 mg in nAMD
NCT07640997Neovascular Age-Related Macular Degeneration (nAMD)
DrugAflibercept
Peking University People's Hospital
Observational
300
Beijing, Fuzhou, Shenzhen, Zunyi, Harbin, Nanyang, Wuhan, Hohhot
2025-11-11
Not yet open
Peking University People's Hospital
Phase 1/2
138
Beijing
2025-10-30
Recruiting
Light and Anesthesia
NCT07517484Light, Anesthesia, Sedation
Peking University People's Hospital
Not applicable
66
Beijing
2025-10-03
Recruiting
Peking University People's Hospital
Observational
100
Beijing
2025-09-01
Recruiting
Peking University People's Hospital
Phase 2
132
Beijing
2025-08-19
Recruiting
Peking University People's Hospital
Phase 1
18
Beijing
2025-08-18
Recruiting
Peking University People's Hospital
Phase 1
18
Beijing
2025-08-18
Recruiting
ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer
NCT06970912Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer
DrugDalpiciclib
Peking University People's Hospital
Phase 2
393
Beijing
2025-08-01
Not yet open
Peking University People's Hospital
Phase 2
132
Beijing
2025-07-30
Recruiting
Real-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients
NCT07296627Newly Diagnosed Multiple Myeloma (NDMM)
Peking University People's Hospital
Observational
500
Beijing
2025-07-16
By invitation
Spontaneous Breathing Mode: A Risk for Hypoxemia During OLV?
NCT07494006Lung Cancer, OLV, Hypoxemia During Surgery
Peking University People's Hospital
Observational
44
Beijing
2025-07-15
Not yet open
Peking University People's Hospital
Phase 2
140
Beijing
2025-07-15
Not yet open
Longitudinal Observational Study on Immune Thrombocytopenia
NCT07068425Immune Thrombocytopenia (ITP)
Peking University People's Hospital
Observational
2,000
Beijing
2025-07-10
Not yet open
Peking University People's Hospital
Phase 2
120
Beijing
2025-07-01
Recruiting
Efficacy of pHA130 Hemoadsorption for 4 Hours (p4H Study)
NCT07111260End Stage Renal Disease on Dialysis
Peking University People's Hospital
Not applicable
34
Beijing
2025-07-01
Recruiting
Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
NCT07359040Non-Small Cell Lung Cancer, Neoadjuvant Therapy, PD-1 Inhibitors, Immunotherapy
DrugsVenetocalx·Ivonescimab
Peking University People's Hospital
Observational
80
Beijing
2025-07-01
Not yet open
Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV
NCT06986018Idiopathic Inflammatory Myopathies, ANCA-Associated Vasculitis
DrugRD06
Peking University People's Hospital
Early Phase 1
12
Beijing
2025-06-14
Recruiting
FAP-targeted PET/NIR in Lung Malignant Tumors
NCT07498933Non-Small Cell Lung Cancer, PET/CT, Neoadjuvant Therapy
Peking University People's Hospital
Observational
200
Beijing
2025-06-03
Recruiting
Peking University People's Hospital
Observational
210
Beijing
2025-06-01
Not yet open
Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk
NCT07010588Hepatocellular Carcinoma (HCC), Magnetic Resonance Imaging (MRI), Randomized Controlled Trial
Peking University People's Hospital
Not applicable
1,389
Beijing, Chongqing, Handan, Harbin, Wuhan, Changchun, Jinan, Qingdao
2025-06
By invitation
Mass Spectrometry-based Immune Profiling in Autoimmune Diseases
NCT07188285Systemic Lupus Erthematosus, Sjogren's Syndrome, Inflammatory Myopathies, Systemic Sclerosis (SSc)
Peking University People's Hospital
Observational
500
Beijing
2025-05-25
Recruiting
Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT
NCT06984536Myelodysplastic Syndrome, Acute Leukemia
Peking University People's Hospital
Phase 2
40
Beijing
2025-05-21
Not yet open
Peking University People's Hospital
Phase 2
100
Beijing
2025-05-20
Recruiting
Peking University People's Hospital
Observational
100
Beijing
2025-05-08
Recruiting
Peking University People's Hospital
Phase 2
56
Beijing
2025-05-01
Recruiting
Peking University People's Hospital
Not applicable
30
Beijing
2025-04-21
Active, closed
Effects of HIPEC on Postoperative Bowel Motility and Complications
NCT07353177HIPEC, Gastro Intestinal Cancer, Adhesion Prevention, Bowel Functions
Peking University People's Hospital
Observational
193
Beijing
2025-04-20
Active, closed
Peking University People's Hospital
Not applicable
86
Beijing
2025-04-05
Not yet open
Application-Assisted Weight Management in Endometrial Cancer Fertility Preservation
NCT06901778Endometrial Cancer, Mobile Applications, Weight Management
Peking University People's Hospital
Not applicable
106
Beijing
2025-03-31
Recruiting
Peking University People's Hospital
Not applicable
20
Beijing
2025-03-29
Recruiting
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
NCT06930807Non-small Cell Lung Cancer, Minimal Residual Disease, Adaptive Treatment
Peking University People's Hospital
Not applicable
1,000
Beijing
2025-03-25
Active, closed
Autologous Fecal Microbiota Transplantation for Anal Function Recovery After Ileostomy Reversal in Rectal Cancer
NCT07711509Rectal Cancer, Low Anterior Resection Syndrome, Fecal Incontinence, Diversion Colitis
Peking University People's Hospital
Not applicable
35
Beijing
2025-03-25
Recruiting
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07569055Invasive Fungal Disease, Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Peking University People's Hospital
Observational
6,000
Beijing
2025-03-15
Not yet open
Peking University People's Hospital
Phase 2
30
Beijing
2025-03-10
Recruiting
Peking University People's Hospital
Not applicable
68
Beijing
2025-03-01
Active, closed
Peking University People's Hospital
Not applicable
105
Beijing, Zhengzhou
2025-03-01
Recruiting
KPD Consolidation After ASCT in NDMM Patients
NCT06879379Multiple Myeloma, Newly Diagnosed
Peking University People's Hospital
Phase 2/3
202
Beijing, Shanghai
2025-03
Recruiting
Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL
NCT06874946Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T - Cell Lymphoma, PTCL
Peking University People's Hospital
Phase 1/2
30
Beijing
2025-02-14
Recruiting
Peking University People's Hospital
Not applicable
81
Beijing
2025-01-10
By invitation
Peking University People's Hospital
Observational
100
Beijing
2025-01-09
Recruiting
Endoscopic and Robotic NSM with Immediate Prosthesis Breast Reconstruction
NCT06748677Nipple-sparing Mastectomy, Immediate Prosthesis Reconstruction, Endoscopic Surgery, Robotic Surgery
Peking University People's Hospital
Observational
484
Beijing
2025-01-03
Recruiting
Vitreous Zonule in Primary Angle-Closure Glaucoma
NCT07523139Primary Angle-Closure Glaucoma
Peking University People's Hospital
Observational
440
Beijing
2025-01-01
Active, closed
Peking University People's Hospital
Observational
200
Beijing
2025-01-01
Recruiting
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
NCT06794008Systemic Lupus Erythematosus, Inflammatory Myopathy, Systemic Sclerosis (SSc), ANCA-associated Vasculitis
Peking University People's Hospital
Phase 2
50
Beijing
2024-12-26
Recruiting
Peking University People's Hospital
Observational
163
Beijing, Wuhan, Zhengzhou
2024-12-09
Not yet open
Peking University People's Hospital
Not applicable
128
Beijing
2024-12-01
Recruiting
Peking University People's Hospital
Phase 1
30
Beijing
2024-12-01
Recruiting
Peking University People's Hospital
Not applicable
100
Beijing, Harbin
2024-12-01
Active, closed
Treatment Duration of IPA
NCT06583512Invasive Aspergillosis, Antifungal Therapy
Peking University People's Hospital
Observational
15
Beijing
2024-12-01
Not yet open
Pralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell Lymphoma
NCT06671717Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma
Peking University People's Hospital
Not applicable
25
Beijing
2024-12
Active, closed
Ultrasound-based Artificial Intelligence for Classification of Carpal Tunnel Syndrome
NCT06697392Carpal Tunnel Syndrome (CTS), Ultrasound, Artificial Intelligence (AI)
Peking University People's Hospital
Observational
500
Beijing
2024-11-15
Recruiting
Peking University People's Hospital
Phase 1/2
30
Beijing
2024-11-15
Recruiting
Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL
NCT06880913Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Peking University People's Hospital
Phase 1/2
50
Beijing
2024-11-14
Recruiting
Peking University People's Hospital
Phase 2
50
Beijing
2024-11-13
Recruiting
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
NCT06727669Immune Thrombocytopenia, Thrombotic Thrombocytopenic Purpura, Hemophilia A, Acquired, Disseminated Intravascular Coagulation
Peking University People's Hospital
Observational
3,000
Beijing, Zhengzhou, Chongqing
2024-11-01
Recruiting
Peking University People's Hospital
Observational
283
Beijing
2024-11-01
Recruiting
Peking University People's Hospital
Observational
50
Beijing, Harbin, Nanjing, Shenyang, Xi'an
2024-10-26
Recruiting
Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia
NCT06581081Relapsed Adult ALL, B-cell Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia, Relapsed Pediatric ALL
Peking University People's Hospital
Not applicable
130
Beijing
2024-10-01
Recruiting
A RWS of SC MTX in Chinese RA Patients
NCT07463937Rheumatoid Arthritis (RA)
Peking University People's Hospital
Observational
10,000
Beijing
2024-09-03
Recruiting
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
NCT06549855Endometrial Cancer, Endometrioid Carcinoma, Mismatch Repair Deficiency
DrugSintilimab
Peking University People's Hospital
Not applicable
10
Beijing
2024-09-02
Recruiting
Peking University People's Hospital
Observational
3,000
Beijing
2024-09-01
Active, closed
Peking University People's Hospital
Observational
70
Beijing
2024-09-01
Recruiting
Clinical Study of a New Treatment Model for Elderly Lung Cancer Patients
NCT07632664Lung Neoplasm, Thoracic Surgical Procedures, Perioperative Care, Postoperative Rehabilitation
Peking University People's Hospital
Not applicable
1,000
Beijing
2024-08-01
Not yet open
Peking University People's Hospital
Phase 2
48
Beijing
2024-08-01
Recruiting
Second Haplo-transplantation for Graft Failure
NCT06512519Graft Failure, Stem Cell Transplant Complications
Peking University People's Hospital
Not applicable
34
Beijing
2024-07-01
Recruiting
Peking University People's Hospital
Observational
30
Beijing, Chengdu, Guangdong, Kunming, Nanjing, Nanning, Nanyang, Ningbo
2024-07-01
Recruiting
Modified Second Haplo-transplantation for Graft Failure
NCT06512545Graft Failure, Stem Cell Transplant Complications
Peking University People's Hospital
Not applicable
12
Beijing
2024-07-01
Recruiting
Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer
NCT06468215Carcinoma, Endometrioid, Fertility Preservation
Peking University People's Hospital
Not applicable
16
Beijing
2024-06-21
Not yet open
Peking University People's Hospital
Observational
260
Beijing
2024-06-20
Recruiting
Peking University People's Hospital
Phase 2
20
Beijing, Guangzhou
2024-06-15
Recruiting
MRD Response-adapted Allo-HSCT for Adverse-risk AML
NCT06301425Acute Myeloid Leukemia
Peking University People's Hospital
Not applicable
178
Beijing
2024-05-24
Recruiting
Peking University People's Hospital
Not applicable
60
Beijing
2024-05-01
Recruiting
Peking University People's Hospital
Not applicable
30
Beijing
2024-04-25
Recruiting
Peking University People's Hospital
Phase 1
44
Jina, Beijin, Beijing
2024-03-25
Recruiting
Peking University People's Hospital
Observational
300
Beijing
2024-01-08
Recruiting
MCB vs EUS-FNA for Preoperative Pathological Evaluation of Gastric SMT
NCT06748690Gastrointestinal Stromal Tumor of Stomach, Submucosal Tumor of Stomach
Peking University People's Hospital
Not applicable
96
Beijing
2024-01-01
Recruiting
Haplo-HSCT for Myelofibrosis
NCT06674382Myelofibrosis
Peking University People's Hospital
Not applicable
39
Beijing
2024-01-01
Recruiting
B7-H3 NIR Imaging for Osteosarcoma Surgery
NCT06778603Osteosarcoma, Resection Margins, B7-H3 Probe, Local Recurrence
Peking University People's Hospital
Phase 1/2
32
Beijing
2024-01-01
Recruiting
Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT
NCT06130579Myeloid Leukemia, Myelodysplastic Syndromes
DrugIFN-α
Peking University People's Hospital
Phase 2
35
Beijing
2024-01-01
Recruiting
Off-the-shelf CD123 CAR-NK for R/R AML
NCT06201247Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
Peking University People's Hospital
Early Phase 1
12
Beijing
2023-12-30
Active, closed
Peking University People's Hospital
Phase 2
30
Beijing
2023-09-10
Recruiting
Peking University People's Hospital
Phase 3
218
Beijing, Guangzhou
2023-08-03
Recruiting
Peking University People's Hospital
Observational
756
Beijing
2023-07-01
Recruiting
Peking University People's Hospital
Observational
120
Beijing
2023-06-01
Recruiting
Frontline of ASCT in High-risk DLBCL
NCT05831865Diffuse Large B Cell Lymphoma
Peking University People's Hospital
Observational
175
Beijing
2023-05-03
Recruiting
Peking University People's Hospital
Phase 2
38
Beijing
2023-04-01
Recruiting
Peking University People's Hospital
Phase 3
96
Beijing
2023-01-01
Not yet open
Peking University People's Hospital
Phase 2
26
Beijing
2023-01
Active, closed
Primary Cervical Cancer Screening by Self-sampling HPV Test
NCT05613283Human Papillomavirus Infection, Cervical Cancer, Negative For Intraepithelial Lesion Or Malignancy, Atypical Squamous Cells of Undetermined Significance
Peking University People's Hospital
Observational
17,875
Beijing, Zhengzhou, Changsha, Chengdu, Hangzhou
2022-11-19
Recruiting
Peking University People's Hospital
Phase 2
64
Beijing
2022-10-01
Recruiting
The Beijing Angle Closure Progression Study
NCT05563623Angle-Closure Glaucoma
Peking University People's Hospital
Observational
825
Beijing
2022-08-04
Recruiting
Multiomics Tumor Evolution Model of NSCLC
NCT05352035Non-small Cell Lung Cancer
Peking University People's Hospital
Observational
300
Beijing
2022-04-20
Recruiting
Peking University People's Hospital
Not applicable
240
Beijing
2022-04-01
Recruiting
Peking University People's Hospital
Observational
45
Beijing
2022-01-01
Recruiting
Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer
NCT05647109Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia
Peking University People's Hospital
Observational
244
Beijing
2021-09-01
Recruiting
Peking University People's Hospital
Phase 1/2
46
Beijing
2021-04-02
Recruiting
Peking University People's Hospital
Phase 1/2
46
Beijing
2021-03-28
Recruiting
Peking University People's Hospital
Observational
1,000
Beijing
2020-05-21
Recruiting
Peking University People's Hospital
Not applicable
654
Beijing
2020-05-12
Recruiting
Peking University People's Hospital
Observational
380
Beijing
2019-01-01
Recruiting
Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer
NCT05945407Endometrial Neoplasms, Endometrial Neoplasm Malignant, Endometrial Neoplasm Malignant Stage I, Carcinoma, Endometrioid
Peking University People's Hospital
Not applicable
57
Beijing
2016-08-01
Active, closed
Peking University People's Hospital
Observational
349
Beijing
2015-12-25
Recruiting
Peking University People's Hospital
Observational
2,000
Beijing
2005-11-01
Rows per page Showing 1–166 of 166
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/beijing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 166 of those studies with a site in Beijing that also match the filters currently applied.

How many clinical trials are recruiting in Beijing?

111 of the 166 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 37 have not yet opened recruitment, 14 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beijing), 166 studies
PhaseStudiesRecruitingShare
Observational594035.5%
Not applicable483228.9%
Phase 2331619.9%
Phase 1/2985.4%
Early Phase 1653.6%
Phase 1553%
Phase 3432.4%
Phase 2/3110.6%
Phase 4110.6%

Most active sponsors

Lead sponsors with the most studies (Beijing)
Lead sponsorStudiesRecruiting
Peking University People's Hospital166111
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.